Lönsjö Jenny, Rydén Martin, Turkiewicz Aleksandra, Hughes Velocity, Tjörnstand Jon, Önnerfjord Patrik, Englund Martin, Ali Neserin
Clinical Epidemiology Unit, Orthopedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Department of Orthopedics, Skåne University Hospital, Lund, Sweden.
Front Immunol. 2025 Jun 23;16:1523103. doi: 10.3389/fimmu.2025.1523103. eCollection 2025.
Synovial fluid contains proteins that may have been released from surrounding tissues, our aim was to gain new insights into the proteomic profiles of human synovial fluid in knees with and without osteoarthritis (OA).
We used synovial fluid from 11 patients with end-stage medial compartment knee OA, aspirated during total knee replacement, and from 13 deceased donors who had no prior history of knee OA (healthy controls). These samples were analyzed using high-multiplex immunoassays Olink. The differential expression of proteins between the groups was analyzed using a linear mixed effects model. The linear associations between pairs of protein expressions were estimated with a linear regression model.
We found that almost half of the detected proteins were differentially expressed between the OA and non-OA controls. The proteins that were most elevated in the OA group compared to controls were tartrate-resistant acid phosphatase type 5 (fold change 10.6, 95% CI [6.6-17.0]), plasminogen activator inhibitor 1 (5.0 [3.1, 8.0]), coagulation factor XI (4.3 [2.6-6.8]) and urokinase-type plasminogen activator (4.3 [2.3-6.8]). The proteins with lower levels in OA compared to controls were fatty acid-binding protein, adipocyte (0.03 [0.02-0.05]), myocilin (0.05 [0.03-0.08]) and carbonic anhydrase 3 (0.14 [0.09-0.23]). The protein-protein co-expression analysis suggests an overall lower number of protein pairs that show co-expression in OA.
There is a substantial change in protein abundance in synovial fluid in end-stage knee OA, suggesting that global joint homeostasis is severely deranged. Our findings suggest altered co-expression between the immune response and extracellular matrix organization in end-stage knee OA, in comparison to non-OA controls.
滑液中含有可能从周围组织释放的蛋白质,我们的目的是深入了解患骨关节炎(OA)和未患骨关节炎的膝关节中人类滑液的蛋白质组学特征。
我们使用了11例终末期内侧间室膝关节OA患者在全膝关节置换术中抽取的滑液,以及13例生前无膝关节OA病史的已故供体(健康对照)的滑液。这些样本使用Olink高多重免疫分析法进行分析。使用线性混合效应模型分析两组之间蛋白质的差异表达。用线性回归模型估计蛋白质表达对之间的线性关联。
我们发现,几乎一半检测到的蛋白质在OA组和非OA对照组之间存在差异表达。与对照组相比,OA组中升高最明显的蛋白质是5型抗酒石酸酸性磷酸酶(倍数变化10.6,95%可信区间[6.6 - 17.0])纤溶酶原激活物抑制剂1(5.0 [3.1, 8.0])、凝血因子XI(4.3 [2.6 - 6.8])和尿激酶型纤溶酶原激活物(4.3 [2.3 - 6.8])。与对照组相比,OA组中水平较低的蛋白质是脂肪酸结合蛋白、脂肪细胞型(0.03 [0.02 - 0.05])、肌纤蛋白(0.05 [0.03 - 0.08])和碳酸酐酶3(0.14 [0.09 - 0.23])。蛋白质-蛋白质共表达分析表明,在OA中显示共表达的蛋白质对总数总体较少。
终末期膝关节OA患者滑液中的蛋白质丰度有显著变化,表明整体关节内环境稳定严重紊乱。我们的研究结果表明,与非OA对照组相比,终末期膝关节OA患者免疫反应与细胞外基质组织之间存在共表达改变。